Testing effectiveness (Phase 2)Study completedNCT00292695What this trial is testingA Phase II Study of Nasal NK/T-cell LymphomaWho this might be right forLymphoma National Health Research Institutes, Taiwan 33
Testing effectiveness (Phase 2)Study completedNCT04323657What this trial is testingTC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+3 more TCR2 Therapeutics 6
Very early researchLooking for participantsNCT04227015What this trial is testingCTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological MalignancyWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma He Huang 72
Early research (Phase 1)Study completedNCT00361049What this trial is testingDonor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantWho this might be right forCancer Case Comprehensive Cancer Center 49
Not applicableNo Longer AvailableNCT01196208What this trial is testingA Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001Who this might be right forDisease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin+1 more Seagen Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515What this trial is testingProvision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior TransplantationWho this might be right forAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more St. Jude Children's Research Hospital 170
Large-scale testing (Phase 3)Looking for participantsNCT07300514What this trial is testingGolidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell LymphomaWho this might be right forMaintenance Treatment of Peripheral T-cell Lymphoma Fudan University 136
Testing effectiveness (Phase 2)Active Not RecruitingNCT04984837What this trial is testingStudy of Lacutamab in Peripheral T-cell LymphomaWho this might be right forPeripheral T Cell LymphomaRelapse/Recurrence The Lymphoma Academic Research Organisation 49
Testing effectiveness (Phase 2)Looking for participantsNCT05934513What this trial is testingGFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Who this might be right forRelapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Genfleet Therapeutics (Shanghai) Inc. 95
Not applicableLooking for participantsNCT05620680What this trial is testingCD7 CAR-T Cells in T-cell Lymphoma/LeukemiaWho this might be right forT Lymphoblastic Leukemia/Lymphoma Shenzhen University General Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07717580What this trial is testingEfficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)Who this might be right forCutaneous T-Cell Lymphoma/Mycosis FungoidesPrimary Cutaneous Anaplastic Large Cell Lymphoma Peking University First Hospital 46
Testing effectiveness (Phase 2)Study completedNCT00156013What this trial is testingClofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)Who this might be right forLymphoma, B-CellLymphoma, Non-Hodgkin Oncology Specialists, S.C. 33
Early research (Phase 1)Study completedNCT02071888What this trial is testingStudy of the Glutaminase Inhibitor CB-839 in Hematological TumorsWho this might be right forNon-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more Calithera Biosciences, Inc 25
Not applicableEnded earlyNCT00651716What this trial is testingT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT03586999What this trial is testingNivolumab With Standard of Care Chemotherapy for Peripheral T Cell LymphomasWho this might be right forPeripheral T Cell Lymphoma University of Colorado, Denver 18
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Testing effectiveness (Phase 2)Study completedNCT00726700What this trial is testingPegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin LymphomaWho this might be right forLymphoma Universität des Saarlandes 109
Testing effectiveness (Phase 2)Ended earlyNCT03547700What this trial is testingStudy of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)Who this might be right forLymphoma, T-Cell, Peripheral University of Michigan Rogel Cancer Center 11
Early research (Phase 1)Study completedNCT00012207What this trial is testingBiological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00448357What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 54